yugatech x infinix

Nothing Phone (3a), Phone (3a) Pro official-looking renders, video trailers leak

Listen to article

Following last week’s leak about the Nothing Phone (3a) Series’ key specs and cameras, the lineup has surfaced again in a new leak revealing their designs.

At first glance, the two phones look nearly identical, with only a notable difference in their camera island designs. The vanilla Phone (3a) has three lenses arranged horizontally, while the Phone (3a) Pro’s sensors and flash are positioned in a half-spiral within a circular camera module.

As previously reported, both phones do sport a 50-megapixel primary camera and an 8-megapixel ultrawide lens. Though the Pro model adds a 3x periscope lens, while the vanilla model has a telephoto lens capped at 2x optical zoom.

Their selfie cameras also vary, with the Pro offering a 50-megapixel front camera, while the Phone (3a) has a 32-megapixel one.

Both models still feature Nothing’s signature transparent, industrial look along with the Glyph Interface lighting at the rear.

The leaked images had long been deleted from the source at Nothing’s request for removal.

In addition, leaker Arsène Lupin shared official-looking reveal videos, giving more details on the phones’ specs and designs.

Both models are equipped with the Snapdragon 7s Gen 3 chipset and 6.77-inch 120Hz AMOLED displays. The videos also highlight a new physical button that activates an AI assistant. Then, there’s a feature called “Essential Space,” which appears to function as an AI-powered to-do list.

The Nothing Phone (3a) Series is scheduled for launch on March 4 during the Mobile World Congress in Barcelona.

Source (1)

React to this article:
Written by
JM Chavaria

JM Chavaria

Senior Writer

JM's highest stat is probably his curious ardor to anything tech—electronics and gaming in particular. He certainly heeds utmost regard to specsheet, visuals, and rule of thirds. If creativity and wit sometimes leave JM's system, watching films, anime and a good stroll for memes are his approved therapeutic claims.

View all posts by JM Chavaria →

0 Comments

Leave a Reply

Loading next article...